Last reviewed · How we verify
NCT04469777
Subcutaneous Injection of Erythropoietin on Visual Functions in Patients With Late Onset Optic Neuropathy
Phase 1, PHASE2 trial testing erythropoietin in Optic Neuropathy in 20 participants. Completed in 30 December 2020.
15 December 2020
Quick facts
| Lead sponsor | Alexandria University |
|---|---|
| Phase | Phase 1, PHASE2 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 1 April 2019 |
| Primary completion | 15 December 2020 |
| Estimated completion | 30 December 2020 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- erythropoietin — full drug profile →
Conditions studied
- Optic Neuropathy — all drugs for Optic Neuropathy →
Sponsor
Alexandria University
Who can join
Adults 18 to 80, any sex, with Optic Neuropathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aimed to investigate the therapeutic effect of subcutaneous erythropoietin in the management of late stage optic neuropathy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04469777
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of erythropoietin
Trials testing the same drug.
- NCT06135259 — Topical Erythropoietin Hydrogel in Management of Oral Lichen Planus · Phase 3 · unknown
- NCT04502537 — Roxadustat for Anemia in Patients With CKD · unknown
- NCT03882060 — Effect of Recombinant Human EPO on the Postoperative Neurologic Outcome in Pediatric Moyamoya Patients · NA · unknown
- NCT03776851 — Erythropoietin in Hemolytic Uremic Syndrome · Phase 4 · completed
- NCT03061565 — Long Term Effects of Erythropoietin in Patients With Moderate to Severe Traumatic Brain Injury · completed
Other recruiting trials for Optic Neuropathy
Currently open trials in the same condition.
- NCT06662448 — Repetitive Transorbital Alternating Current Stimulation for Optic Neuropathies · NA · recruiting
Other Alexandria University trials
Trials by the same sponsor.
- NCT07517861 — Integrated Mental Health Nursing Program: Effects on Stigma, Cognitive Flexibility, and Clinical Readiness · NA · recruiting
- NCT07476482 — The Impact of a Shared Decision-Making Intervention on Intraoperative Patient Experience During Elective Cesarean Delive · NA · enrolling by invitation
- NCT07476209 — Sialendoscopy Versus Photobiomodulation in Prevention of Radiation Induced Xerostomia · NA · recruiting
- NCT07503626 — Optimization of Orthodontic Bracket Placement by Using Two Different Protocols of Digitally Aided Bonding · NA · recruiting
- NCT07522944 — AI-Guided Relaxation for Hemodialysis Anxiety · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04469777 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Alexandria University
- Last refreshed: 1 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04469777.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing